1Reaven,G.Banting lecture 1988.Role of insulin resistance in human disease[J].Am Diabetes Associ,1988;37(12):1595-607.
2International Diabetes Federation:The IDF consensus worldwide definition of the metabolic syndrome 〔article online〕.Available from http://www.idf.org/webdata/docs/metac_syndrome_def.pdf.Accessed on 19 October,2005.
3Alberti KG,Shaw ZP.IDF Epidemiology task force consensus group,the metabolic syndrome-a new worldwide definition[J]. Lancet,2005;366(9491):1059-62.
4Ford ES.A comparison of the prevalence of the metabolic syndrome using two proposed definitions [J].Diabetes Care,2003;26(3):575-81.
5WHO.Definition,diagngsis and classification of diabetes mellitus and its complication [M].WHO/NCD/NCS,1999:31-2.
6Expert Panel on Detection,Evaluation and Treatment of High Blood Cholesteril in Adults.Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on deteetion,evaluation,and treatment of high bloodcholesterol in adults (Adult Treatment Panel Ⅲ) [J].JAMA,2001;285(19):2486-97.
8Kahn R,Ferrannini E.The metabolic syndrome:time for a critical appraisal:joint statement from the American Diabetes Association and the European Association for the study of diabetes [J].Diabetes Care,2005;28(9):2289-304.
9Gale EA.The myth of the metabolic syndrome [J].Diabetologia,2005;48(9):1679-83.
10Grundy SM,Cleeman JI,Daniels SR,et al.Diagnosis and management of the metabolic syndrome.An American Heart Association/National Heart,Lung,and Blood Institute Scientific Statement.Executive summary [J].Cardiol Rev,2005;13(6):322-7.
1Matsumoto K,Fujita N,Nakamura K,et al.Apolipoprotein B and insuli resistance are good markers of carotid atherosclerosis in patients with type2 diabetes mellitus(J).Diabetes Res Clin Pract,2008;82(1):93-7.
2Colao A,Spiezia S,Di Somma C,et al.Circulating insulin-like growth fac-tor-1 levels are correlated with the atherosclerotic profile in healthy sub-jects independently of age(J).J Endocrinol Invest,2005;28(5):440-8.
3Brismar K,Ferngvist-Forbes E,Wahren J,et al.Effect of insulin on thehepatic production of insulin-like growth factor-binding protein-1(IGFBP-1),IGFBP-3,and IGF-1 in insulin dependent diabetes(J).J Clin Endo-crinol Metab,1994;79(3):872-8.
4Thomas GN,Critchley JA,Tomlinson B,et al.Albuminuria and the renin-angiotensin system gene polymorphisms in type-2-diabetic and in normo-glycemic hypertensive Chinese(J).Clin Nephrol,2001;55(1):7-15.
5Grundy SM,Cleeman JI,Daniels SR,et al.Diagnosis and management of the metabolic syndrome.An American Heart Association/National Heart,Lung,and Blood Institute Scientific Statement.Executive summary(J).Cardiol Rev,2005;13(6):322-7.
6Alberti K,Eckel RH,Grundy SM. Harmonizing the metabolic syndrome a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention;National Heart,Lung,and Blood Institute;American Heart Association;World Heart Federation;International Atherosclerosis Society;and International Association for the Study of Obesity[J].{H}CIRCULATION,2009,(16):1640-1645.
7Echahidi N,Mohty D,Pibarot P. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery[J].{H}CIRCULATION,2007,(11 suppl):I213-I219.
8Lorenzo C,Williams K,Hunt KJ. The National Cholesterol Education Program-Adult Treatment Panel Ⅲ,International Diabetes Federation,and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes[J].{H}DIABETES CARE,2007,(01):8-13.
9Guize L,Thomas F,Pannier B. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions[J].{H}DIABETES CARE,2007,(09):2381-2387.
10Moebus S,Balijepalli C,L(o)sch C. Age-and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome-a cross-sectional study[J].{H}Cardiovascular Diabetology,2010,(01):1-12.
